<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">4. Discussion</segment>
<segment id="2" parent="1002" relname="span">Diet interventions are well-established strategies</segment>
<segment id="3" parent="1003" relname="joint">to reduce body weight</segment>
<segment id="4" parent="5" relname="concession">and improve glucose metabolism ,</segment>
<segment id="5" parent="1004" relname="span">however no evidence exists about the effects of periodic fasting on NAFLD .</segment>
<segment id="6" parent="1007" relname="span">This study is the first</segment>
<segment id="7" parent="6" relname="purpose">to show the beneficial effects of periodic fasting on fatty liver .</segment>
<segment id="8" parent="1008" relname="span">The results of our study supported the hypothesis</segment>
<segment id="9" parent="8" relname="elaboration">that FLI , a surrogate parameter of fatty liver , significantly decreases in individuals with and without T2DM after a fasting intervention of at least 6 days .</segment>
<segment id="10" parent="1010" relname="span">The prospective study design</segment>
<segment id="11" parent="10" relname="attribution">according to a standardized protocol with a well-established fasting technique and a close clinical monitoring was a strength of this study .</segment>
<segment id="12" parent="1005" relname="joint">Weight reduction and improvement of fatty liver indicators are known to be interrelated .</segment>
<segment id="13" parent="14" relname="attribution">Our results indicate</segment>
<segment id="14" parent="1013" relname="span">that even a modest reduction of BMI improved surrogate markers of fatty liver .</segment>
<segment id="15" parent="1016" relname="span">Indeed , in nearly half of the subjects in the highest risk category</segment>
<segment id="16" parent="15" relname="elaboration">( FLI &gt; 60 ) ,</segment>
<segment id="17" parent="1017" relname="span">a BMI reduction of less than 5 % was sufficient</segment>
<segment id="18" parent="17" relname="purpose">to induce a shift to a lower risk category .</segment>
<segment id="19" parent="1018" relname="sequence">In most patients , NAFLD is associated with features of metabolic syndrome , central obesity , elevated blood pressure , dyslipidemia , hyperglycemia , and insulin resistance .</segment>
<segment id="20" parent="1020" relname="span">Although these pathologies can be addressed by lifestyle interventions , in daily life the adherence to the necessary lifestyle changes is poor ,</segment>
<segment id="21" parent="20" relname="elaboration">resulting in suboptimal outcomes .</segment>
<segment id="22" parent="1019" relname="joint">In contrast , in pragmatic programs there is a greater benefit in a more substantial weight loss , particularly at early stages of the intervention period .</segment>
<segment id="23" parent="1019" relname="joint">Hence , periodic fasting can significantly reduce weight ,</segment>
<segment id="24" parent="1019" relname="joint">and this effect can be maintained over time .</segment>
<segment id="25" parent="1019" relname="joint">There are several concerns about the adverse effects of fasting .</segment>
<segment id="26" parent="1027" relname="span">Several non-fatal</segment>
<segment id="27" parent="26" relname="elaboration">( e. g. , headache )</segment>
<segment id="28" parent="1029" relname="span">and rarely fatal</segment>
<segment id="29" parent="28" relname="elaboration">( e. g. , ventricular arrhythmia )</segment>
<segment id="30" parent="1028" relname="same_unit">events have been reported .</segment>
<segment id="31" parent="1034" relname="span">In contrast , no severe adverse events were found in a cohort of 1422 subjects</segment>
<segment id="32" parent="31" relname="elaboration">treated with a periodic fasting</segment>
<segment id="33" parent="1034" relname="evidence">lasting 4 â€“ 21 days , .</segment>
<segment id="34" parent="1033" relname="elaboration">Michalsen et al. evaluated the acceptance , safety , effects on health-related outcomes , and lifestyle adherence of fasting therapy in different chronic internal diseases .</segment>
<segment id="35" parent="1032" relname="elaboration">They found no serious adverse events throughout their study .</segment>
<segment id="36" parent="1036" relname="span">Our study supports the hypothesis</segment>
<segment id="37" parent="1037" relname="span">that fasting therapy</segment>
<segment id="38" parent="37" relname="elaboration">provided in a controlled clinical setting is a safe intervention .</segment>
<segment id="39" parent="1039" relname="span">There is a large body of evidence on the beneficial effects of carbohydrate restriction and hypocaloric diets on NAFLD .</segment>
<segment id="40" parent="41" relname="attribution">It has also been shown</segment>
<segment id="41" parent="1041" relname="span">that-at equal levels of weight reduction-a carbohydrate-restricted diet leads to a significantly greater intrahepatic triglyceride reduction than low-calorie diet alone .</segment>
<segment id="42" parent="1042" relname="span">The metabolic advantage of carbohydrate restriction appears to be related to a more pronounced lipid oxidation and enhanced ketogenesis .</segment>
<segment id="43" parent="1043" relname="joint">In recent years , intermittent and periodic fasting has gained popularity as an alternative to continuous caloric restriction .</segment>
<segment id="44" parent="1044" relname="span">In addition to the weight loss effects ,</segment>
<segment id="45" parent="1045" relname="span">periodic fasting is associated with several metabolic benefits ,</segment>
<segment id="46" parent="45" relname="elaboration">including the improvement of lipid profiles .</segment>
<segment id="47" parent="1019" relname="joint">This has been also shown for intermittent fasting , e. g. , Ramadan fasting .</segment>
<segment id="48" parent="1048" relname="span">The key mechanism</segment>
<segment id="49" parent="48" relname="elaboration">responsible for many of these beneficial effects is the metabolic switch from the utilization of glycogenolysis-derived glucose to fatty acids and fatty acid-derived ketones , i. e. , a fundamental switch from lipid synthesis and fat storage to mobilization of fat in the form of free fatty acids and fatty acid-derived ketones .</segment>
<segment id="50" parent="1019" relname="joint">This occurs between 12 and 36 hours after cessation of food consumption .</segment>
<segment id="51" parent="1019" relname="joint">Hyperinsulinemia suppresses ketogenesis</segment>
<segment id="52" parent="1052" relname="span">and therefore prolongs the time</segment>
<segment id="53" parent="52" relname="purpose">to switch in cases of obesity , insulin resistance , and T2DM .</segment>
<segment id="54" parent="1056" relname="span">Although there is some evidence of impaired ketogenesis during the progression of liver disease to steatohepatitis ,</segment>
<segment id="55" parent="1057" relname="span">therapies</segment>
<segment id="56" parent="55" relname="elaboration">that increase hepatic ketogenesis are expected nonetheless to ameliorate NAFLD .</segment>
<segment id="57" parent="1058" relname="span">Our data provided first evidence</segment>
<segment id="58" parent="1059" relname="span">that periodic fasting leads to a clearance of liver fat :</segment>
<segment id="59" parent="1060" relname="joint">fasting significantly reduced FLI</segment>
<segment id="60" parent="1061" relname="span">and increased the proportion of patients without NAFLD</segment>
<segment id="61" parent="60" relname="elaboration">( FLI &lt; 30 units ;</segment>
<segment id="62" parent="1063" relname="preparation">Figure 2</segment>
<segment id="63" parent="1063" relname="span">) .</segment>
<segment id="64" parent="1064" relname="joint">The effects of fasting therapy were stronger in males and in individuals with higher baseline FLI , higher GOT , and higher cholesterol levels .</segment>
<segment id="65" parent="1065" relname="span">Each additional fasting day further decreased the FLI .</segment>
<segment id="66" parent="1067" relname="attribution">The binary logistic regression showed</segment>
<segment id="67" parent="1068" relname="span">that every day of fasting increase by 40 % the chance</segment>
<segment id="68" parent="1069" relname="span">to improve a manifest fatty liver</segment>
<segment id="69" parent="68" relname="elaboration">( FLI &gt; 60 )</segment>
<segment id="70" parent="1067" relname="same_unit">and switch to a lower category of risk .</segment>
<segment id="71" parent="1072" relname="attribution">This implies</segment>
<segment id="72" parent="1072" relname="span">that the duration of fasting must be sufficient</segment>
<segment id="73" parent="72" relname="purpose">to influence fatty liver positively .</segment>
<segment id="74" parent="1074" relname="span">This should be taken into account</segment>
<segment id="75" parent="74" relname="circumstance">when periodic fasting is considered as treatment for NAFLD .</segment>
<segment id="76" parent="1076" relname="joint">As already mentioned , insulin resistance , T2DM , and the development of NAFLD are closely associated conditions .</segment>
<segment id="77" parent="78" relname="attribution">Taylor et al. have shown</segment>
<segment id="78" parent="1077" relname="span">that remission of T2DM requires a decrease of liver fat .</segment>
<segment id="79" parent="1079" relname="preparation">Patients with T2DM tend to have higher FLI scores ,</segment>
<segment id="80" parent="1081" relname="attribution">but in this study , we could demonstrate</segment>
<segment id="81" parent="1081" relname="span">that the fasting intervention was equally effective in T2DM patients and in non-diabetic subjects in terms of FLI ,</segment>
<segment id="82" parent="1083" relname="span">although the improvement of other parameters</segment>
<segment id="83" parent="82" relname="elaboration">( e. g. , HDL , LDL , and AP )</segment>
<segment id="84" parent="1082" relname="same_unit">was not as complete .</segment>
<segment id="85" parent="1084" relname="span">These results are in line with a previous study on periodic fasting in T2DM .</segment>
<segment id="86" parent="1085" relname="joint">Liver enzymes , insulin resistance , and cholesterol levels are related in NAFLD .</segment>
<segment id="87" parent="1087" relname="span">Our results supported a correlation between changes in FLI and changes in liver enzymes</segment>
<segment id="88" parent="87" relname="elaboration">( GGT , and GOT )</segment>
<segment id="89" parent="1089" relname="span">and lipid parameters</segment>
<segment id="90" parent="89" relname="restatement">( TG )</segment>
<segment id="91" parent="1090" relname="span">after fasting intervention ,</segment>
<segment id="92" parent="91" relname="concession">although this was limited to subjects without T2DM .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1005" relname="background"/>
<group id="1003" type="multinuc" parent="2" relname="purpose"/>
<group id="1004" type="span" parent="1003" relname="joint"/>
<group id="1005" type="multinuc" parent="1001" relname="span"/>
<group id="1006" type="span" parent="1005" relname="joint"/>
<group id="1007" type="span" parent="1006" relname="span"/>
<group id="1008" type="span" parent="1007" relname="elaboration"/>
<group id="1010" type="span" parent="1005" relname="joint"/>
<group id="1013" type="span" parent="1005" relname="joint"/>
<group id="1015" type="multinuc" parent="1005" relname="joint"/>
<group id="1016" type="span" parent="1015" relname="same_unit"/>
<group id="1017" type="span" parent="1015" relname="same_unit"/>
<group id="1018" type="multinuc" parent="1005" relname="joint"/>
<group id="1019" type="multinuc" parent="1018" relname="sequence"/>
<group id="1020" type="span" parent="1019" relname="joint"/>
<group id="1027" type="span" parent="1019" relname="joint"/>
<group id="1028" type="multinuc" parent="1019" relname="joint"/>
<group id="1029" type="span" parent="1028" relname="same_unit"/>
<group id="1031" type="span" parent="1019" relname="joint"/>
<group id="1032" type="span" parent="1031" relname="span"/>
<group id="1033" type="span" parent="1032" relname="span"/>
<group id="1034" type="span" parent="1033" relname="span"/>
<group id="1036" type="span" parent="1019" relname="joint"/>
<group id="1037" type="span" parent="36" relname="elaboration"/>
<group id="1039" type="span" parent="1019" relname="joint"/>
<group id="1040" type="span" parent="39" relname="elaboration"/>
<group id="1041" type="span" parent="1040" relname="span"/>
<group id="1042" type="span" parent="1041" relname="elaboration"/>
<group id="1043" type="multinuc" parent="42" relname="elaboration"/>
<group id="1044" type="span" parent="1043" relname="joint"/>
<group id="1045" type="span" parent="44" relname="elaboration"/>
<group id="1048" type="span" parent="1019" relname="joint"/>
<group id="1052" type="span" parent="1019" relname="joint"/>
<group id="1053" type="span" parent="1019" relname="joint"/>
<group id="1054" type="span" parent="1053" relname="span"/>
<group id="1055" type="span" parent="1054" relname="span"/>
<group id="1056" type="span" parent="1055" relname="span"/>
<group id="1057" type="span" parent="54" relname="elaboration"/>
<group id="1058" type="span" parent="1056" relname="elaboration"/>
<group id="1059" type="span" parent="57" relname="elaboration"/>
<group id="1060" type="multinuc" parent="58" relname="elaboration"/>
<group id="1061" type="span" parent="1060" relname="joint"/>
<group id="1062" type="span" parent="1055" relname="elaboration"/>
<group id="1063" type="span" parent="1062" relname="span"/>
<group id="1064" type="multinuc" parent="63" relname="elaboration"/>
<group id="1065" type="span" parent="1064" relname="joint"/>
<group id="1066" type="span" parent="65" relname="elaboration"/>
<group id="1067" type="multinuc" parent="1066" relname="span"/>
<group id="1068" type="span" parent="1067" relname="same_unit"/>
<group id="1069" type="span" parent="67" relname="purpose"/>
<group id="1070" type="span" parent="1054" relname="elaboration"/>
<group id="1071" type="span" parent="1073" relname="preparation"/>
<group id="1072" type="span" parent="1071" relname="span"/>
<group id="1073" type="multinuc" parent="1070" relname="span"/>
<group id="1074" type="span" parent="1073" relname="joint"/>
<group id="1075" type="multinuc" parent="1073" relname="joint"/>
<group id="1076" type="multinuc" parent="1075" relname="joint"/>
<group id="1077" type="span" parent="1076" relname="joint"/>
<group id="1078" type="span" parent="1075" relname="joint"/>
<group id="1079" type="span" parent="1078" relname="span"/>
<group id="1080" type="span" parent="1079" relname="span"/>
<group id="1081" type="span" parent="1080" relname="span"/>
<group id="1082" type="multinuc" parent="81" relname="concession"/>
<group id="1083" type="span" parent="1082" relname="same_unit"/>
<group id="1084" type="span" parent="1080" relname="elaboration"/>
<group id="1085" type="multinuc" parent="85" relname="elaboration"/>
<group id="1086" type="multinuc" parent="1085" relname="joint"/>
<group id="1087" type="span" parent="1086" relname="joint"/>
<group id="1088" type="multinuc" parent="1086" relname="joint"/>
<group id="1089" type="span" parent="1088" relname="same_unit"/>
<group id="1090" type="span" parent="1088" relname="same_unit"/>
	</body>
</rst>
